A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma
Clinical trial NCT06891560 · RECRUITING
Trial details
- NCT number
- NCT06891560
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-31
- Primary completion
- 2027-03-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.